Responses
Clinical/translational cancer immunotherapy
Original research
Selective IL-1 activity on CD8+ T cells empowers antitumor immunity and synergizes with neovasculature-targeted TNF for full tumor eradication
Compose a Response to This Article
Other responses
No responses have been published for this article.